LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has signed a distributor agreement with the Research Institute for Liver Diseases (RILD) in Shanghai, People’s Republic of China.
Help employers find you! Check out all the jobs and post your resume.